Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure

Nature Cell Biology

Volumn 15, Issue 11, 2013, Pages 1282-1293

  Dirkx, Ellen ^a   Gladka, Monika M ^a   Philippen, Leonne E ^a   Armand, Anne Sophie ^b   Kinet, Virginie ^a   Leptidis, Stefanos ^a,c   El Azzouzi, Hamid ^a,c   Salic, Kanita ^a,c   Bourajjaj, Meriem ^c   Da Silva, Gustavo J J ^d   Olieslagers, Servé ^a   Van Der Nagel, Roel ^e   De Weger, Roel ^e   Bitsch, Nicole ^a   Kisters, Natasja ^a   Seyen, Sandrine ^a   Morikawa, Yuka ^f   Chanoine, Christophe ^b   Heymans, Stephane ^a   Volders, Paul G A ^a   Thum, Thomas ^g,h   Dimmeler, Stefanie ⁱ   Cserjesi, Peter ^j   Eschenhagen, Thomas ^k   Da Costa Martins, Paula A ^a   De Windt, Leon J ^a   more..

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CNRS   (France)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f TEXAS HEART INSTITUTE   (United States)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ GOETHE UNIVERSITY   (Germany)

^j Howard Hughes Medical Institute   (United States)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 25; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HAND2; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; MOUSE; NEWBORN; NONHUMAN; POSTTRANSCRIPTIONAL CONTROL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE SILENCING; HEART FAILURE; HUMANS; MICE; MICE, KNOCKOUT; MICRORNAS; NFATC TRANSCRIPTION FACTORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

MAMMALIA; MURINAE; MUS;

EID: 84887251900     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2866     Document Type: Article

References (64)

1. Olson, E. N. & Schneider, M. D. Sizing up the heart: development redux in disease. Genes Dev. 17, 1937-1956 (2003). (Pubitemid 36999321)
2. Katz, A. M. The cardiomyopathy of overload: an unnatural growth response. Eur. Heart J. 16, 110-114 (1995). (Pubitemid 26082359)
3. Hoshijima, M. & Chien, K. R. Mixed signals in heart failure: cancer rules. J. Clin. Invest. 109, 849-855 (2002). (Pubitemid 34275104)
4. Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
5. Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433-436 (2013).
6. Towbin, J. A. & Bowles, N. E. The failing heart. Nature 415, 227-233 (2002). (Pubitemid 34059529)
7. Oka, T., Xu, J. & Molkentin, J. D. Re-employment of developmental transcription factors in adult heart disease. Semin. Cell Dev. Biol. 18, 117-131 (2007). (Pubitemid 46330840)
8. Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600 (2006). (Pubitemid 44325350)
9. Savage, D. D., Levy, D., Dannenberg, A. L., Garrison, R. J. & Castelli, W. P. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am. J. Cardiol. 65, 371-376 (1990). (Pubitemid 20038922)
10. Meijs, M. F. et al. Left ventricular hypertrophy: a shift in paradigm. Curr. Med. Chem. 14, 157-171 (2007). (Pubitemid 46043911)
11. Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J. & Nemer, M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl Acad. Sci. USA 101, 6975-6980 (2004). (Pubitemid 38596428)
12. Oka, T. et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98, 837-845 (2006).
13. Bar, H., Kreuzer, J., Cojoc, A. & Jahn, L. Upregulation of embryonic transcription factors in right ventricular hypertrophy. Basic Res. Cardiol. 98, 285-294 (2003). (Pubitemid 37107655)
14. Song, K. et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125, 453-466 (2006).
15. Bourajjaj, M. et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J. Biol. Chem. 283, 22295-22303 (2008).
16. Molkentin, J. D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998). (Pubitemid 28180855)
17. Freund, C. et al. Requirement of nuclear factor-κB in angiotensin IIand isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111, 2319-2325 (2005). (Pubitemid 40647067)
18. Li, Y. et al. NF-κB activation is required for the development of cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 287, H1712-H1720 (2004). (Pubitemid 39313278)
19. Wang, J. et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ. Res. 97, 821-828 (2005). (Pubitemid 41447133)
20. Xu, J. et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ. Res. 98, 342-350 (2006).
21. Buitrago, M. et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat. Med. 11, 837-844 (2005). (Pubitemid 41161115)
22. Saadane, N., Alpert, L. & Chalifour, L. E. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 278, H796-H805 (2000). (Pubitemid 30152536)
23. Srivastava, D., Cserjesi, P. & Olson, E. N. A subclass of bHLH proteins required for cardiac morphogenesis. Science 270, 1995-1999 (1995). (Pubitemid 26097190)
24. Cross, J. C. et al. Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development 121, 2513-2523 (1995).
25. Hollenberg, S. M., Sternglanz, R., Cheng, P. F. & Weintraub, H. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell Biol. 15, 3813-3822 (1995).
26. Srivastava, D. et al. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nature Genet. 16, 154-160 (1997). (Pubitemid 27240613)
27. Biben, C. & Harvey, R. P. Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHand during murine heart development. Genes Dev. 11, 1357-1369 (1997). (Pubitemid 27259848)
28. Thomas, T., Yamagishi, H., Overbeek, P. A., Olson, E. N. & Srivastava, D. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Dev. Biol. 196, 228-236 (1998). (Pubitemid 28198849)
29. Morikawa, Y. & Cserjesi, P. Cardiac neural crest expression of Hand2 regulates outflow and second heart field development. Circ. Res. 103, 1422-1429 (2008).
30. Snider, P., Olaopa, M., Firulli, A. B. & Conway, S. J. Cardiovascular development and the colonizing cardiac neural crest lineage. Sci. World J. 7, 1090-1113 (2007). (Pubitemid 47036152)
31. Hutson, M. R. & Kirby, M. L. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol. 18, 101-110 (2007). (Pubitemid 46343796)
32. Rockman, H. A. et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl Acad. Sci. USA 88, 8277-8281 (1991). (Pubitemid 21915339)
33. Subramaniam, A. et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613-24620 (1991). (Pubitemid 21908985)
34. De Windt, L. J. et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ. Res. 86, 255-263 (2000). (Pubitemid 30108817)
35. Zhang, Z. et al. The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning. Dev. Biol. 351, 254-265 (2011).
36. Sohal, D. S. et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25 (2001). (Pubitemid 34135487)
37. Koitabashi, N. et al. Avoidance of transient cardiomyopathy in cardiomyocyte targeted tamoxifen-induced MerCreMer gene deletion models. Circ. Res. 105, 12-15 (2009).
38. Koitabashi, N. et al. Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J. Clin. Invest. 121, 2301-2312 (2011).
39. Fish, J. E. et al. A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development 138, 1409-1419 (2011).
40. Baker, R. K., Vanderboom, A. K., Bell, G. W. & Antin, P. B. Expression of the receptor tyrosine kinase gene EphB3 during early stages of chick embryo development. Mech. Dev. 104, 129-132 (2001). (Pubitemid 32549774)
41. Mason, I. J., Fuller-Pace, F., Smith, R. & Dickson, C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech. Dev. 45, 15-30 (1994). (Pubitemid 24051373)
42. Dai, Y. S. & Cserjesi, P. The basic helix-loop-helix factor, HAND2, functions as a transcriptional activator by binding to E-boxes as a heterodimer. J. Biol. Chem. 277, 12604-12612 (2002). (Pubitemid 34952619)
43. McFadden, D. G. et al. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 127, 5331-5341 (2000). (Pubitemid 32049189)
44. Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220 (2005). (Pubitemid 41021266)
45. Tanzer, A. & Stadler, P. F. Molecular evolution of a microRNA cluster. J. Mol. Biol. 339, 327-335 (2004). (Pubitemid 38596952)
46. Aramburu, J. et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129-2133 (1999). (Pubitemid 29451431)
47. Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613-618 (2007). (Pubitemid 46828487)
48. da Costa Martins, P. A. et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nature Cell Biol. 12, 1220-1227 (2010).
49. Ganesan, J. et al. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127, 2097-2106 (2013).
50. Van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579 (2007). (Pubitemid 46683138)
51. Ucar, A. et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 3, 1078 (2012).
52. Boon, R. A. et al. MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110 (2013).
53. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
54. Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713 (2009).
55. Morikawa, Y., D'Autreaux, F., Gershon, M. D. & Cserjesi, P. Hand2 determines the noradrenergic phenotype in the mouse sympathetic nervous system. Dev. Biol. 307, 114-126 (2007). (Pubitemid 46890851)
56. Krutzfeldt, J. et al. Silencing of microRNAs in vivo with antagomirs'. Nature 438, 685-689 (2005).
57. Lyakh, L., Ghosh, P. & Rice, N. R. Expression of NFAT-family proteins in normal human T cells. Mol. Cell Biol. 17, 2475-2484 (1997). (Pubitemid 27175128)
58. Wilkinson, D. G., Bailes, J. A., Champion, J. E. & McMahon, A. P. A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development 99, 493-500 (1987). (Pubitemid 17057493)
59. De Windt, L. J., Lim, H. W., Haq, S., Force, T. & Molkentin, J. D. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 275, 13571-13579 (2000). (Pubitemid 30257424)
60. Van Oort, R. J. et al. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114, 298-308 (2006). (Pubitemid 44297096)
61. Liang, Q. et al. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276, 30245-30253 (2001).
62. Van Rooij, E. et al. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy. J. Biol. Chem. 277, 48617-48626 (2002). (Pubitemid 35470824)
63. Armand, A. S. et al. Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. J. Biol. Chem. 283, 29004-29010 (2008).
64. Luo, C. et al. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell Biol. 16, 3955-3966 (1996). (Pubitemid 26199915)